Become an SSRP Member to view this page
Join thousands of providers who have transformed their practices through evidence-based cellular medicine. Members pay 30% less on all courses, certifications, and events.
Article
Jun 10, 2025
Mastermind 14: The Brain Code – Digital On-Demand
Cole Morris
RELATED RESOURCES
Continue exploring related topics.
VIEW ALL
SSRP Institute
Aug 27, 2026
Rasonque: An FDA-Approved Drug to Treat Pancreatic Cancer
BREAKING NEWS August 26, 2026 – The Food and Drug Administration on Wednesday approved daraxonrasib, sold as Rasonque, for adults with metastatic pancreatic adenocarcinoma, the most common form of pancreatic cancer and one long considered among the hardest to treat. The once-daily tablet, developed by Revolution Medicines, is the first targeted therapy approved for the […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Aug 24, 2026
Ep. 102 - Office Hours: PWC26 Virtual Summit Part 4
Preview Only
Office Hours PWC26 Virtual Summit Part 4 – Episode 102
Office Hours PWC26 Virtual Summit Part 4- Episode 102
- Compounded topical creams and GHK-Cu with microneedling (0:59)
- Detoxing before using copper (12:09)
- Patient onboarding process (12:54)
- Zinc and iron supplementation with GHK-Cu (23:41)
- Loss of taste after COVID (25:55)
- 3D CT scans for root canals (27:03)
- Oral bacteria swabs and GLP-1 effectiveness (28:00)
- Endocannabinoid system (29:07)
- GHK-Cu efficacy on wound beds (32:05)
Preview Only — Become a member for full access
SSRP Institute
Aug 21, 2026
Alpha-Gal Syndrome: An Update on Incidence Rate by the CDC
HEADLINE SCIENCE JAMA recently published a report about the incidence rate of alpha-gal syndrome, which is a serious allergic reaction to a sugar molecule called alpha-gal, which is found in most mammals. It is typically transmitted through a bite from a Lone Star tick or other tick species that injects the molecule into the body, […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Aug 17, 2026
Ep. 101 - Office Hours: PWC26 Virtual Summit Part 3
Preview Only
Office Hours PWC26 Virtual Summit Part 3 – Episode 101
Office Hours PWC26 Virtual Summit Part 3 – Episode 101
1. Mitochondrial peptides (1:07)
2. MOTS-c cycle (3:50)
3. Injury site specific injection (9:25)
4. BPC-157 dosing (15:18)
5. Trusted labs (20:56)
6. What “redox” means (25:48)
7. Patient with cervical fusion, pain, and decreased range of motion (31:36)
8. Lipedema (37:03)
9. SS-31 and MOTS-c (37:52)
10. NanoVI device (44:49)
11. NAD (48:13)
Preview Only — Become a member for full access
IntellxxDNA
Aug 12, 2026
SSRP Institute Welcomes IntellxxDNA as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [August 12, 2026] — The SSRP Institute welcomes IntellxxDNA to its Trusted Partner Network following a nomination and internal vetting process, aligning with SSRP’s mission to advance science-first, education-driven clinical collaboration. IntellxxDNA provides clinicians with a structured genomic decision support platform that translates complex genetic data into clinically actionable insights. Using […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Aug 10, 2026
Ep. 100 - Office Hours: PWC26 Virtual Summit Part 2
Preview Only
Office Hours PWC26 Virtual Summit Part 2 – Episode 100
Office Hours PWC26 Virtual Summit Part 2 – Episode 100
- Evaluating terrain of the patient (1:43)
- SS31 peptide in practice (8:50)
- Phenotyping the right patient for GLP-1 therapy (11:18)
Preview Only — Become a member for full access
William Seeds, MD
Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
Mitochondrial dysfunction is one of the most firmly established hallmarks of aging, but the field has spent far more energy describing genetic causes of mitochondrial failure—mtDNA mutation, defective OXPHOS, impaired unfolded protein response—than the “natural” drivers that erode mitochondria during ordinary aging. As I discussed in my recent June Journal Club (as well as a […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Aug 3, 2026
Ep. 099 - Office Hours: PWC26 Virtual Summit Part 1
Preview Only
Office Hours: PWC26 Virtual Summit Part 1 – Episode 099
Office Hours: PWC26 Virtual Summit Part 1 – Episode 099
This special edition of Office Hours features questions submitted during the Peptide World Congress Virtual Summit on July 10 and 11. Dr. Seeds and Dr. Newman address:
- GLOW Stack, MOTS c, and Thyroid Function (0:50)
- Should the GLOW Stack Be Separated? (3:31)
- Peptides in Transplant Medicine (8:02)
- Biomarker Monitoring (13:21)
- Peptides in Acute and Long Term Stroke Recovery (17:37)
- Autoimmunity and the GI Tract (23:00)
- Cancer Concerns Related to Hormones and Angiogenesis (26:49)
Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Jul 27, 2026
Ep. 098 - Pentosan Polysulfate: Dosing, Safety, and Monitoring
Preview Only
Dissecting Protocols – Episode 098
Pentosan Polysulfate: Dosing, Safety, and Monitoring
Dr. Seeds examines the subcutaneous use of pentosan polysulfate, addressing concerns about injection site scarring and ocular safety. He discusses dosing, site rotation, cumulative exposure, retinal screening, and strategies for responsible, individualized treatment.(Question Link)
Preview Only — Become a member for full access
SSRP Institute
Jul 24, 2026
PCAC Meeting Vote Summary
BREAKING NEWS JULY 24, 2026 – The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDA’s 503A Bulks List.Recommended FOR inclusion: (Yes-No)• BPC-157 (8–6)• KPV (8–6)• TB-500 (8–6)• MOTS-c (7–5)• Epitalon (7–4)• Semax (8–5)Recommended AGAINST inclusion: (Yes-No)• DSIP (6–7) What happens […]
READ NEWS